# The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

> **NCT02838589** · PHASE2 · COMPLETED · sponsor: **Christina Kruuse** · enrollment: 30 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Byetta
- **DRUG:** Isotonic saline

## Key facts

- **NCT ID:** NCT02838589
- **Lead sponsor:** Christina Kruuse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838589, "The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02838589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*